Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00338_DB06237_nanopub.RAsxaZVb-Jd9yXBApjEca2ozsVwyPq6nH3Ulj3mVnWrHc#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00338_DB06237 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00338_DB06237 label "DDI between Omeprazole and Avanafil - Nineteen healthy male volunteers received a single 40 omeprazole delayed-release capsule once daily for 8 days (Days 1-8), and a single 200 mg avanafil on Day 8. Twelve hour pharmacokinetics of omeprazole on Days 7 and 8 were compared. Co-administration with avanafil resulted in an approximate 5.9% increase in AUC0-inf and 8.6% increase in Cmax of omeprazole. [drugbank_resource:DB00338_DB06237]" assertion.
- drugbank_resource:DB00338_DB06237 identifier "drugbank_resource:DB00338_DB06237" assertion.
- drugbank_resource:DB00338_DB06237 title "DDI between Omeprazole and Avanafil - Nineteen healthy male volunteers received a single 40 omeprazole delayed-release capsule once daily for 8 days (Days 1-8), and a single 200 mg avanafil on Day 8. Twelve hour pharmacokinetics of omeprazole on Days 7 and 8 were compared. Co-administration with avanafil resulted in an approximate 5.9% increase in AUC0-inf and 8.6% increase in Cmax of omeprazole." assertion.
- drugbank:DB00338 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00338_DB06237 assertion.
- drugbank:DB06237 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00338_DB06237 assertion.